Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Post by steadfaston Dec 02, 2021 12:43pm
243 Views
Post# 34190723

Can Frank Hollyer perform as Executive Chairman?

Can Frank Hollyer perform as Executive Chairman? I, among many other shareholders felt he was useless as SVA Chairman.
I did not vote for him last AGM.  I understand he has performed well in the
past with other companies.  Let's tell him to JUST GET THE JOB DONE AND
NOW.  If I were him, I would immediately:

1.  Have Life Science phone GINA KOLATA, NY Times - Have I got a story for you,
one that is much better than you recently wrote re Diabetes.  LIfe Sciences have
the data, our patients are brittle diabetics, the sickest of the sickest, and relay
our study of Patient #1.  Have Life Sciences review VX-880 one year to reduce
HbA1c 1% from Baseline.  SVA wins this one.

Arrange for Life Sciences to get top quality news coverage for SVA.

2.  Time for Ray Matthews & Life Sciences to perform or "out the door".
At time of typing this,  35,000 shares traded on TSX, DJ +632.
Days of Old Boys Club is over.

3.  Time to sign a deal with a Device Manufacturer and Big Pharma that is
best for shareholders.

4.  Time for Cannacord to keep their promise of an Analyst Report.

5.  How about JDRF US Website include SVA & U of Chicago Clinical Trial,
SVA should get coverage, not just ViaCyte.

6.  Keep SVA well ahead of the competition



<< Previous
Bullboard Posts
Next >>